Dr. Emilio Torres-Netto presented ELZA-PACE cross-linking at BRASCRS 2025, a customised, tissue-preserving keratoconus vision rehabilitation method with promising clinical outcomes.
CAIRS for keratoconus: Prof Hafezi and Dr. Torres-Netto are featured in Ocular Surgery News, in which CAIRS experts highlight its role in rehabilitating highly irregular corneas.
ELZA’s CEO, Nikki Hafezi launches a keratoconus screening initiative for children with Down syndrome in Uzbekistan, beginning in Andijan.
ECO-CAIRS extends tissue-based keratoconus surgery by optimizing allogenic ring segments through extracorporeal cross-linking.
At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.
Hafezi addressed the widespread reliance on a 1986 prevalence estimate that places keratoconus at 1 in 2,000—formally classifying it as rare. Yet as she highlighted, emerging epidemiological data tell a starkly different story. Keratoconus is an orphan disease, not a rare one.
A teenage boy nearly lost his sight to keratoconus from chronic eye rubbing. Discover how early diagnosis and Swiss treatment saved it.
At the WCC 2025 congress in Washington, DC, Dr. Emilio A. Torres-Netto of the ELZA Institute presented groundbreaking research on ELZA-PACE-CXL, ELZA-sub400 CXL, and Femto-CAIRS, pushing the boundaries of keratoconus treatment.
ELZA-PACE combines epi-on cross-linking with customized PTK for keratoconus without stromal tissue removal – as reported by Ocular Surgery News
Ocular Surgery News interviewed Prof. Farhad Hafezi at ESCRS 2025 on ECO-CAIRS, a technique using ultra high-fluence corneal cross-linking (CXL) to optimize allogenic corneal ring segments before implantation, improving precision and biomechanical stability.
